Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma

• Isabel J.F. Hofman,
• Stephanie Patchett,
• Mark van Duin,
• Ellen Geerdens,
• Jelle Verbeeck,
• Lucienne Michaux,
• Michel Delforge,
• Pieter Sonneveld,
• Arlen W. Johnson,
• Kim De Keersmaecker

Affiliations

Isabel J.F. Hofman

Department of Oncology, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium

Stephanie Patchett

Department of Molecular Biosciences, The University of Texas at Austin, TX, USA

Mark van Duin

Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

Ellen Geerdens

Center for Cancer Biology, VIB, Leuven, Belgium;Center for Human Genetics, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium

Jelle Verbeeck

Department of Oncology, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium

Lucienne Michaux

Center for Human Genetics, KU Leuven - University Hospitals Leuven, Belgium

Michel Delforge

LKI - Leuven Cancer Institute, Department of Development and Regeneration, KU Leuven - University Hospitals Leuven, Belgium

Pieter Sonneveld

Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

Arlen W. Johnson

Department of Molecular Biosciences, The University of Texas at Austin, TX, USA

Kim De Keersmaecker

Department of Oncology, KU Leuven - University of Leuven, LKI - Leuven Cancer Institute, Belgium